The vast majority of patients with prostate cancer in the United States don’t receive androgen deprivation therapy injections on time. Up to 84% of injections are delayed for patients on a 28-day schedule, according to an authoritative study published in the The Journal of Urology.
COTA joined Panalgo’s Partner Network to make their hematologic oncology data available via Panalgo’s Instant Health Data Analytics platform.
